1. Жиляева Т. В. Предменструальные расстройства настроения: этиология, патогенез, диагностика и лечение. Problemy Reproduktsii 2015.
2. Crowley T., Cryan J. F., Downer E. J., O’Leary O. F. Inhibiting Neuroinflammation: The Role and Therapeutic Potential of GABA in Neuro-Immune Interactions. Brain Behav. Immun. 2016, 54, 260-277.
3. Wu C., Qin X., Du H., Li N., Ren W., Peng Y. The Immunological Function of GABAergic System. Front. Biosci. 2017, 22, 1162-1172.
4. Ossewaarde L., Hermans E. J., van Wingen G. A., Kooijman S. C., Johansson I.-M., Bäckström T., Fernández G. Neural Mechanisms Underlying Changes in Stress-Sensitivity across the Menstrual Cycle. Psychoneuroendocrinology 2010, 35, 47-55.
5. Bäckström T., Haage D., Löfgren M., Johansson I. M., Strömberg J., Nyberg S., Andréen L., Ossewaarde L., van Wingen G. A., Turkmen S. et al. Paradoxical Effects of GABA-A Modulators May Explain Sex Steroid Induced Negative Mood Symptoms in Some Persons. Neuroscience 2011, 191, 46-54.
6. Bannister E. There Is Increasing Evidence to Suggest That Brain Inflammation Could Play a Key Role in the Aetiology of Psychiatric Illness. Could Inflammation Be a Cause of the Premenstrual Syndromes PMS and PMDD? Post Reprod Health 2019, 25, 157-161.
7. Endicott J., Nee J., Harrison W. Daily Record of Severity of Problems (DRSP): Reliability and Validity. Arch. Womens. Ment. Health 2006, 9, 41-49.
8. Nakajima S. T., Brumsted J. R., Riddick D. H., Gibson M. Absence of Progestational Activity of Oral Spironolactone. Fertil. Steril. 1989, 52, 155-158.
9. Genazzani A. R., Mannella P., Simoncini T. Drospirenone and Its Antialdosterone Properties. Climacteric 2007, 10 Suppl 1, 11-18.
10. de Nadai M. N., Nobre F., Ferriani R. A., Vieira C. S. Effects of Two Contraceptives Containing Drospirenone on Blood Pressure in Normotensive Women: A RandomizedControlled Trial. Blood Press. Monit. 2015, 20, 310-315.
11. Cagnacci A., Ferrari S., Napolitano A., Piacenti I., Arangino S., Volpe A. Combined Oral Contraceptive Containing Drospirenone Does Not Modify 24-H Ambulatory Blood Pressure but Increases Heart Rate in Healthy Young Women: Prospective Study. Contraception 2013, 88, 413-417.
12. de Morais T. L., Giribela C., Nisenbaum M. G., Guerra G., Mello N., Baracat E., Consolim-Colombo F. M. Effects of a Contraceptive Containing Drospirenone and Ethinylestradiol on Blood Pressure, Metabolic Profile and Neurohumoral Axis in Hypertensive Women at Reproductive Age. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, 182, 113-117.
13. El Amki M., Binder N., Steffen R., Schneider H., Luft A. R., Weller M., Imthurn B., Merki-Feld G.S., Wegener S. Contraceptive Drugs Mitigate Experimental Stroke-Induced Brain Injury. Cardiovasc. Res. 2019, 115, 637-646.
14. Lopez L. M., Kaptein A. A., Helmerhorst F. M. Oral Contraceptives Containing Drospirenone for Premenstrual Syndrome. Cochrane Database Syst. Rev. 2012, CD 006586.
15. Wichianpitaya J., Taneepanichskul S. A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms. Obstet. Gynecol. Int. 2013, 2013, 487143.
16. Хаджиева Н. Х., Кузнецова И. В. Возможности КОК-ДРСП у женщин со стресс-зависимыми нарушениями менструального цикла. Медицинский алфавит. 2021, 26, 23-27.
17. Тихомиров А. Л. Комплаентность КОК: доступное повышение качества жизни. Gynecology.